Abstract: Techniques are provided for tracking heartrate metrics using different operating modes associated with different contexts of a wearable device. For example, a heartrate sensor of the wearable device may be operated in a first operating mode when an activity is being tracked within an application session of a particular application. The heartrate sensor may be operated in a second operating mode after detecting conclusion of the activity within the activity session (e.g., during sedentary time).

Abstract: A device (200) which includes a monitoring unit (210), a therapy unit (220), and a display (100) that includes a touch screen (110). The monitoring unit (210) can be configured to monitor a person's vital signs, such as a person's electrocardiogram (ECG). The therapy unit (220) can be configured to administer an electric shock. The display (100) can be configured to display the ECG and enable a user to scroll the displayed ECG back and forth and/or to zoom in and zoom out the displayed ECG by touching the touch screen (110). The display (100) can also be configured to enable the user to select two or more separate segments of the ECG to view together at the same time on the display (100), which segments can be separated by intervening segments of the ECG that can be hidden from being viewed on the display (100). The display (100) can have multiple user-interface windows (120, 130).

Abstract: The implant comprises a tubular body housing an energy harvesting module adapted to convert external stresses applied to the implant into electrical energy, and a rechargeable battery adapted to be charged by the energy harvesting module. During the storage, an external source physically separated from the implant is coupled to the implant rechargeable battery to maintain a minimum battery charge level. An interface circuit of the implant couples surface electrodes to the battery, with switching between: i) a transport and storage configuration where the electrodes are connected to the external source to receive from the latter a battery charging energy and/or to exchange communication signals with the outside through the wire link of the coupling; and ii) a functional configuration in which the surface electrodes are decoupled from the external source after the implant has been implanted.

Abstract: The invention provides a blood pump for use with an intravascular ventricular assist system (iVAS), as well as a method for utilizing the blood pump to treat heart failure.

Abstract: An implantable system, and methodology, for improving a heart's hemodynamic performance featuring (a) bimodal electrodes placeable on the diaphragm, out of contact with the heart, possessing one mode for sensing cardiac electrical activity, and another for applying cardiac-cycle-synchronized, asymptomatic electrical stimulation to the diaphragm to trigger biphasic, diaphragmatic motion, (b) an accelerometer adjacent the electrodes for sensing both heart sounds, and stimulation-induced diaphragmatic motion, and (c) circuit structure, connected both to the electrodes and the accelerometer, operable, in predetermined timed relationships to the presences of valid V-events noted in one of sensed electrical and sensed mechanical, cardiac activity, to deliver diaphragmatic stimulation.

Abstract: A method of treating an overactive bladder condition includes providing a stimulation device having a generator enclosing a primary cell that is coupled to circuitry, and a lead coupling an electrode assembly to the generator, where the circuitry is operable to generate a stimulation signal with a duty cycle of between 0.1% and 2.5% and a total average current drain from the primary cell of between 0.1 ?A and 5 ?A, with the total average current drain including a background current plus a stimulation current weighted by the duty cycle; forming an incision in skin of a patient diagnosed with the overactive bladder condition; implanting the stimulation device in the patient by inserting the stimulation device into the incision in the skin of the patient; and closing the incision.

Abstract: Techniques are disclosed for a multi-tier system for predicting cardiac arrhythmia in a patient. In one example, a computing device processes parametric patient data and provider data for a patient to generate a long-term probability that a cardiac arrhythmia will occur in the patient within a first time period. In response to determining that the cardiac arrhythmia is likely to occur within the first time period, the computing device causes a medical device to process the parametric patient data to generate a short-term probability that the cardiac arrhythmia will occur in the patient within a second time period. In response to determining that the cardiac arrhythmia is likely to occur within the second time period, the medical device performs a remediative action to reduce the likelihood that the cardiac arrhythmia will occur.

Abstract: A handheld light treatment device that aims to provide a wide variety of uses in personal care and household cleaning. The device contains a panel with light sources positioned behind a translucent or transparent head plate, to which is attachable an applicator disc and, optionally, applicator disc attachments with selected functionalities. The light panel shines light of different frequencies that may be useful for cleaning and sanitizing various surfaces. The applicator disc and applicator disc attachments have a substantially translucent or transparent base, allowing light from the light sources to shine through the head plate as well as applicator disc and applicator disc attachment, and the applicator disc to rotate while the light panel remains fixed. The applicator disc and applicator disc attachments may have bristles or other surface elements to facilitate cleaning or other uses, and the device may dispense an ingredient.

Abstract: Hemodynamic performance of a heart may be improved by determining, from a location associated with a diaphragm, an occurrence of a valid cardiac event; and then delivering asymptomatic electrical stimulation therapy directly to the diaphragm at termination of a diaphragmatic stimulation delay period that is timed relative to the occurrence of the valid cardiac event. The diaphragmatic stimulation delay period may be automatically established by sensing a plurality of cardiac events directly from a diaphragm; and for each of the sensed cardia events, determining whether the sensed cardiac event represents a valid cardiac event or a non-valid cardiac event. The diaphragmatic stimulation delay period is then calculated based on a plurality of sensed cardia events that are determined to be valid.

Abstract: The invention relates to a method and a cochlear implant system comprising; a microphone unit configured to receive an acoustical signal and transmit an audio signal based on the acoustical signal, a processor unit configured to receive the audio signal and process the audio signal into a plurality channels that are then used to generate a plurality of electrode pulses, an electrode array including a plurality of electrodes (M) configured to stimulate auditory nerves of a user of the cochlear implant system based on the plurality of electrode pulses, and wherein the processor unit is configured to assign an importance value to one or more electrodes of the plurality of electrodes, wherein each of the importance values is determined based on a status of an electrode pulse assigned to the respective electrode, and wherein the status of the electrode pulse of the plurality of electrode pulses is determined based on a masking model of across-electrode interferences imposed on that electrode pulse by other electro

Abstract: Embodiments described herein relate to implantable medical devices (IMDs) and methods for use therewith. Such a method includes using an accelerometer of an IMD (e.g., a leadless pacemaker) to produce one or more accelerometer outputs indicative of the orientation of the IMD. The method can also include controlling communication pulse parameter(s) of one or more communication pulses (produced by pulse generator(s)) based on accelerator output(s) indicative of the orientation of the IMD. The communication pulse parameter(s) that is/are controlled can be, e.g., communication pulse amplitude, communication pulse width, communication pulse timing, and/or communication pulse morphology. Such embodiments can be used to improve conductive communications between IMDs whose orientation relative to one another may change over time, e.g., due to changes in posture and/or due to cardiac motion over a cardiac cycle.

Abstract: A pulsed laser skin treatment device is for laser induced optical breakdown of hair or skin tissue. The device has a light exit window to be placed against a surface to be treated such as skin during use. A feedback system is used for determining a state of contact between the light exit window and the surface. To this end the feedback system is capable of detecting a feedback signal representative for the state of contact. If the feedback signal or the state of contact is such that the risk of skin surface or device damage by the device operation is too high, the user or the device has a way to interrupt the treatment or to reduce light output to reduce or eliminate this risk.

Abstract: A wearable medical device is provided for monitoring the cardiac health of a patient, for example, for indications of cardiac anomalies, where the device includes ECG sensors in electrical contact with the patient's body, therapy electrodes for providing electrical therapy to the patient's heart, and a control unit having at least one touch control with force sensor disposed on its housing for contacting with a finger. Signals from the touch control may be analyzed to identify force application below a first force threshold and at or above a second force threshold below the first force threshold, and, responsive to detecting such application of force, user input may be registered. User inputs to the at least one touch control may be used to delay therapy by the therapy electrodes.

Abstract: A method and system are provided for continuous monitoring perfusion of an organ or extremity, and for early detection of progressive partial occlusion of arterial blood supply or venous drainage of tissue. The method and system measure a delay in wave propagation of a blood perfusion wave, which is associated with flow of blood through a blood vessel. The delay is correlated to an amount of obstruction in the blood vessel.

Abstract: A method of treating motor deficits in a stroke patient, comprising assessing a patient's motor deficits, determining therapeutic goals for the patient, based on the patient's motor deficits, selecting therapeutic tasks based on the therapeutic goals, performing each of the selected therapeutic tasks repetitively, observing the performance of the therapeutic tasks, initiating the stimulation of the vagus nerve manually at approximately a predetermined moment during the performance of the therapeutic tasks, stimulating the vagus nerve of the patient during the performance of the selected therapeutic tasks, and improving the patient's motor deficits.

Abstract: This invention generally relates to methods useful for measuring heart rate, respiration conditions, and oxygen saturation and a wearable device that incorporate those methods with a computerized system supporting data collection, analysis, readout and sharing. Particularly this present invention relates to a wearable device, such as a wristwatch or ring, for real time measuring heart rate, respiration conditions, and oxygen saturation.

Abstract: A medical apparatus configured to neuromodulate tissue and/or record patient information is provided. The apparatus includes an external system to transmit transmission signal(s), each signal having at least power or data, and an implantable system to receive the transmission signal(s). The data transfer between the external and implantable systems is asynchronous. The external system includes external antenna(s) to transmit a transmission signal. The transmission signal is an amplitude modulated signal modulated by varying a load on the external antenna(s) that causes an impedance mismatch prior to amplifying the signal for transmission. An implantable device includes implantable antenna(s) to receive the transmission signal. The implantable system comprises a receiver to receive the transmission signal from the implantable antenna(s), implantable transmission module(s) to transmit data to the external system, and a variable load connected to the implantable antenna(s).

Abstract: This specification generally relates to a biphasic injectable electrode which comprises a plurality of solid particles and a transporter phase, wherein both the solid particles and the transporter phase comprise poly(3,4-ethylenedioxythiophene)polystyrene sulfonate. The biphasic injectable electrode, in use in a surgical resection cavity in the brain includes inserting the biphasic injectable electrode into a surgical resection cavity in the brain with a tumor resection margin. A probe is inserted into the electrode and four counter electrodes are implanted in the surrounding brain tissue. A charge delivery device delivers charge to the probe via a wire both of which have also been implanted.

Abstract: A system and method for selecting leadwire stimulation parameters includes a processor iteratively performing, for each of a plurality of values for a particular stimulation parameter, each value corresponding to a respective current field: (a) shifting the current field longitudinally and/or rotationally to a respective plurality of locations about the leadwire; and (b) for each of the respective plurality of locations, obtaining clinical effect information regarding a respective stimulation of the patient tissue produced by the respective current field at the respective location; and displaying a graph plotting the clinical effect information against values for the particular stimulation parameter and locations about the leadwire, and/or based on the obtained clinical effect information, identifying an optimal combination of a selected value for the particular stimulation parameter and selected location about the leadwire at which to perform a stimulation using the selected value.

Abstract: This invention corresponds to an electrical and magnetic tissue stimulation device comprising a multi-source distribution circuit, a decoupled output stage circuit connected to the multi-source distribution circuit and to a control unit; the control unit is connected to the multi-source distribution circuit and to the decoupled output stage circuit, where the control unit generates PE and Out outputs for electrical and magnetic stimulation of a tissue. The invention also has a multi-source distribution circuit that comprises a control unit connected to a source output selector. A voltage regulator circuit is connected to a current limiter. The current limiter is connected to a capacitor, to a capacitor bank and to the source output sector, wherein the control unit controls the source output selector by means of an output control signal bus, the source output selector connects or disconnects one or more capacitors from the capacitor bank.